Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
December 04, 2013

Next-Generation Sequencing from Research to the Clinic

The opportunities for NGS as a diagnostic tool are immense.

Next-Generation Sequencing from Research to the Clinic

The FDA approved Illumina’s MiSeqDx platform for the clinic in late November. The report below shows how that approval may affect the market. [Select Biosciences]

Related content